Strong EHDEN/OHDSI Presence at ICPE21
The International Society for Pharmacoepidemiology’s virtual ICPE 2021 conference, Real Evidence for the Real World,
The International Society for Pharmacoepidemiology’s virtual ICPE 2021 conference, Real Evidence for the Real World,
EHDEN is pleased to be over half-way in its IMI project phase and to be
Brussels, Belgium, 27 July 2021: EHDEN is delighted to announce that Boehringer Ingelheim has today
Part 3 of the chronicle looks at progress to date since the initial call; here
No one is big enough alone to master the complex future. Curious minds could help here in learning from others and building on accomplished work. It seems that even politicians and decision makers are sharing the same mindset: bringing in more cohesion and bridging different aspirations together is the efficient way forward. Ecosystems and collaboration are the keys for sustainable future despite of the differences.
Sulev Reisberg University of Tartu Introduce yourself and the University of Tartu? The University of
The EHDEN Consortium is pleased to announce that a total of 41 data partners have
Antje Hottgenroth Lilly Introduce yourself and Lilly? Eli Lilly and Company is a global healthcare
The balance to be met is to keep data closed enough for citizen protection, but open enough for research. This means achieving an ethical balance, avoiding any harm to the patient, while doing societal good in research. The use of federated data networks, such as EHDEN, implicitly protect patient data by keeping data local, behind local firewalls and approval processes, inclusive of local consent requirements, whilst aggregating population-level information, not patient-level data from analysis. This is privacy by design.
The largest, most extensive global network study on background rates for adverse events of special